{"nct_id":"NCT04058756","title":"Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2019-10-30","start_date_type":"ACTUAL","primary_completion_date":"2030-04-30","primary_completion_date_type":"ESTIMATED","completion_date":"2030-04-30","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["NVS"]}